EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease

Michael J Foley iD, Christopher A Rajkumar iD, Fiyyaz Ahmed-Jushuf, Florentina Simader iD, Shayna Chotai iD, Henry Seligman iD, Krzysztof Macierzanka, John R Davies, Thomas R Keeble, Peter O'Kane iD, Peter Haworth, Helen Routledge und 17 weitere

Circulation · 21.01.2025 · 151 (3) · 202-214

DOI: 10.1161/circulationaha.124.072281 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 21.01.2025. Verfasst von Michael J Foley und 28 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, United Kingdom (M.J.F., C.A.R., F.A.-J., F.S., S.C., H.S., K.M., S.S.N., R.P., S.S., G.D.…. Hauptthemen laut MEDLINE: Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention, Coronary Artery Disease, Angina, Stable. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, NIHR Biomedical Research Centre, UKRI | Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: ORBITA-2 (the Placebo-Controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina) provided evidence for the role of percutaneous coronary intervention (PCI) for angina relief in stable coronary artery disease. Fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are often used to guide PCI; however, their ability to predict placebo-controlled angina improvement is unknown. METHODS: Participants with angina, ischemia, and stable coronary artery disease were enrolled, and anti-anginal medications were stopped. Participants reported angina episodes daily for 2 weeks using the ORBITA smartphone symptom application (ORBITA-app). At the research angiogram, FFR and iFR were measured. After sedation and auditory isolation, participants were randomized to PCI or placebo before entering a 12-week blinded follow-up phase with daily angina reporting. The ability of FFR and iFR, analyzed as continuous variables, to predict the placebo-controlled effect of PCI was tested using Bayesian proportional odds modeling. RESULTS: Invasive physiology data were available for 279 patients (140 PCI and 139 placebo). The median (interquartile range) age was 65 years (59.0–70.5), and 223 (79.9%) were male. Median FFR was 0.60 (0.46–0.73), and median iFR was 0.76 (0.50–0.86). The lower the FFR or iFR, the greater the placebo-controlled improvement with PCI across all end points. There was strong evidence that a patient with an FFR at the lower quartile would have a greater placebo-controlled improvement in angina symptom score with PCI than a patient at the upper quartile (FFR, 0.46 versus 0.73: odds ratio, 2.01; 95% credible interval, 1.79–2.26; probability of interaction, >99.9%). Similarly, there was strong evidence that a patient with an iFR at the lower quartile would have greater placebo-controlled improvement in angina symptom score with PCI than a patient with an iFR at the upper quartile (iFR, 0.50 versus 0.86: odds ratio, 2.13; 95% credible interval, 1.87–2.45; probability of interaction, >99.9%). The relationship between benefit and physiology was seen in both Rose angina and Rose nonangina. CONCLUSIONS: Physiological stenosis severity, as measured by FFR and iFR, predicts placebo-controlled angina relief from PCI. Invasive coronary physiology can be used to target PCI to those patients who are most likely to experience benefit. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03742050.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fractional Flow Reserve, MyocardialPercutaneous Coronary InterventionCoronary Artery DiseaseAngina, StableHumansMaleFemaleAgedMiddle AgedTreatment OutcomeCoronary AngiographyPredictive Value of Tests

Stichwörter der Autor:innen

angina, stablecardiovascular physiologyclinical trials, randomizedcoronary artery diseaseischemia, myocardial

Autor:innen und Institutionen

  • National Heart and Lung Institute, Imperial College London, United Kingdom (M.J.F., C.A.R., F.A.-J., F.S., S.C., H.S., K.M., S.S.N., R.P., S.S., G.D.C., J.P.H., D.P.F., M.J.S.-S., R.A.-L.).
  • Department of Cardiology, Imperial College Healthcare NHS Trust, London, United Kingdom (M.J.F., C.A.R., F.A.-J., F.S., S.C., H.S., S.S.N., R.P., S.S., G.D.C., J.P.H., D.P.F., M.J.S.-S., R.A.-L.).
  • Department of Cardiology, Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust, Basildon, United Kingdom (J.R.D., T.R.K., G.C.).
  • Medical Technology Research Centre, Anglia Ruskin School of Medicine, Chelmsford, United Kingdom (J.R.D., T.R.K.).
  • Department of Cardiology, University Hospitals of Dorset NHS Foundation Trust, Bournemouth, United Kingdom (P.O., J.D.).
  • Department of Cardiology, Portsmouth Hospitals University NHS Trust, United Kingdom (P.H.).

ORCID-Profile: Michael J Foley, Christopher A Rajkumar, Florentina Simader, Shayna Chotai, Henry Seligman, Peter O'Kane, Tushar Kotecha, Gerald Clesham, Sukhjinder S Nijjer, Nick Curzen, James Spratt, Graham D Cole, Frank E Harrell, James P Howard, Darrel P Francis, Matthew J Shun-Shin, Rasha Al-Lamee

Förderung

  • British Heart Foundation
  • NIHR Biomedical Research Centre
  • UKRI | Medical Research Council
  • National Institute for Health and Care Research
  • Philips
  • Coronary Flow Trust

Zitieren

APA

Foley, M. J., Rajkumar, C. A., Ahmed-Jushuf, F., Simader, F., Chotai, S., Seligman, H., Macierzanka, K., Davies, J. R., Keeble, T. R., O'Kane, P., Haworth, P., Routledge, H., Kotecha, T., Clesham, G., Williams, R., Din, J., Nijjer, S. S., Curzen, N., Sinha, M., …, & ORBITA-2 Investigators (2025). Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease. Circulation, 151(3), 202-214. https://doi.org/10.1161/circulationaha.124.072281

Vancouver

Foley MJ, Rajkumar CA, Ahmed-Jushuf F, Simader F, Chotai S, Seligman H, et al. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease. Circulation. 2025;151(3):202-214. doi:10.1161/circulationaha.124.072281

BibTeX
@article{Foley2025,
  author = {Foley, Michael J and Rajkumar, Christopher A and Ahmed-Jushuf, Fiyyaz and Simader, Florentina and Chotai, Shayna and Seligman, Henry and Macierzanka, Krzysztof and Davies, John R and Keeble, Thomas R and O'Kane, Peter and Haworth, Peter and Routledge, Helen and Kotecha, Tushar and Clesham, Gerald and Williams, Rupert and Din, Jehangir and Nijjer, Sukhjinder S and Curzen, Nick and Sinha, Manas and Petraco, Ricardo and Spratt, James and Sen, Sayan and Cole, Graham D and Harrell, Frank E and Howard, James P and Francis, Darrel P and Shun-Shin, Matthew J and Al-Lamee, Rasha and ORBITA-2 Investigators, ORBITA-2 Investigators},
  title = {Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease},
  journal = {Circulation},
  year = {2025},
  volume = {151},
  number = {3},
  pages = {202--214},
  doi = {10.1161/circulationaha.124.072281}
}
Kostenlos starten →